Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
First Bancorp
FBP
$4.27B
| $19.2M | 0.01% |
1,459,578
+278,361
| +24% | +$3.43M |
|
1352
Affirm
AFRM
$26.1B
| $19.2M | 0.01% |
161,070
-104,256
| -39% | -$8.33M |
|
|
PIAI
1353
DELISTED
Prime Impact Acquisition I
PIAI
| $19.1M | 0.01% |
1,949,431
| – | – |
|
1354
Rambus
RMBS
$9.75B
| $19.1M | 0.01% |
860,483
+557,270
| +184% | +$13.1M |
|
1355
GrafTech
EAF
$175M
| $19M | 0.01% |
184,441
-14,547
| -7% | -$1.59M |
|
1356
Corsair Gaming
CRSR
$1.28B
| $19M | 0.01% |
732,748
+696,987
| +1,949% | +$20M |
|
1357
Dave & Buster's
PLAY
$350M
| $19M | 0.01% |
495,040
+407,718
| +467% | +$14.7M |
|
1358
GameStop
GME
$8.12B
| $19M | 0.01% |
432,032
-274,952
| -39% | -$12.6M |
|
|
IIAC
1359
DELISTED
Investindustrial Acquisition Corp.
IIAC
| $18.9M | 0.01% |
1,908,073
+650,245
| +52% | +$6.44M |
|
1360
iShares MSCI Hong Kong ETF
EWH
$1.27B
| $18.9M | 0.01% |
789,650
+658,856
| +504% | +$17M |
|
|
AFTR.U
1361
DELISTED
AfterNext HealthTech Acquisition Corp Units
AFTR.U
| $18.9M | 0.01% |
+1,900,000
| New | +$18.9M |
|
1362
Varex Imaging
VREX
$780M
| $18.9M | 0.01% |
670,199
+367,932
| +122% | +$10.2M |
|
|
LGAC
1363
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
| $18.9M | 0.01% |
1,941,496
+204,315
| +12% | +$1.99M |
|
1364
CALL
Quest Diagnostics
DGX
$27B
| $18.9M | 0.01% |
130,000
+29,100
| +29% | +$4.26M |
|
1365
Dominion Energy
D
$58.9B
| $18.9M | 0.01% |
258,519
-949,652
| -79% | -$72.4M |
|
1366
Moog Inc Class A
MOG.A
$11.9B
| $18.9M | 0.01% |
247,413
+105,340
| +74% | +$8.23M |
|
1367
Sony
SONY
$141B
| $18.9M | 0.01% |
852,785
-670,515
| -44% | -$14M |
|
1368
CALL
Teleflex
TFX
$5.94B
| $18.8M | 0.01% |
50,000
+20,000
| +67% | +$7.79M |
|
1369
Oneok
OKE
$57.8B
| $18.8M | 0.01% |
324,559
-313,886
| -49% | -$16.9M |
|
1370
Standard BioTools
LAB
$255M
| $18.8M | 0.01% |
2,852,514
-530,143
| -16% | -$3.49M |
|
1371
CALL
Humana
HUM
$46.8B
| $18.8M | 0.01% |
48,300
+11,800
| +32% | +$5.01M |
|
1372
PUT
Martin Marietta Materials
MLM
$37.8B
| $18.8M | 0.01% |
55,000
+42,700
| +347% | +$15.5M |
|
1373
Herc Holdings
HRI
$5.22B
| $18.7M | 0.01% |
114,337
+40,532
| +55% | +$5.14M |
|
1374
CVR Energy
CVI
$3.81B
| $18.7M | 0.01% |
1,121,383
+174,477
| +18% | +$2.46M |
|
|
NARI
1375
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $18.7M | 0.01% |
230,081
-164,439
| -42% | -$13.8M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.